Drug application

CORDRAN (FLURANDRENOLIDE)

Drugs@FDA NDA 016455 · ALMIRALL

Key facts

Drug name CORDRAN
Active ingredients FLURANDRENOLIDE
Application type NDA
Application number 016455
Company ALMIRALL
Dosage forms TAPE, TOPICAL
Strength 0.004MG/SQ CM
Marketing status Prescription
Reference listed drug Yes
Latest submission class Type 3 - New Dosage Form
Latest submission status date Jul 29, 1969

At a glance

  • 1–9 Submissions
  • 10–99 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications